Skip to the page

Data / Drug companies / Guangzhou Tata Biotechnology Co., Ltd.

Guangzhou Tata Biotechnology Co., Ltd.: 9 products in the FDA NDC directory, labeler code 84066

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Guangzhou Tata Biotechnology Co., Ltd. (labeler code 84066) lists 9 products in the FDA National Drug Code Directory, covering 6 finished drugs by generic name. By type: 9 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on June 4, 2026.

The request: Watch Guangzhou Tata Biotechnology Co., Ltd. (FDA labeler code 84066): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84066
Products in commercial distribution
9
Packages
9
Finished drugs by generic name
6
Prescription products
0
Over the counter products
9
Flagged as original packager
9 of 9 products that carry the flag
Started marketing in the last 12 months
3
Earliest marketing start
January 25, 2024
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs9100%

Products by type

TypeProductsShare
Over the counter drugs9100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Ethylhexyl methoxycinnamate, octocrylene11
Zinc pyrithione110
Zinc oxide, titanium dioxide144
Zinc oxide,titanium dioxide12
Capsaicin166
Zinc oxide , titanium dioxide11

Dosage forms

Dosage formProductsShare
Cream666.7%
Gel111.1%
Liquid111.1%
Lipstick111.1%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Medultima adventure sunscreen84066-109CreamOver the counter monograph drugsJune 4, 2026
NeroCare Capsaicin Neuropathy Relief Cream84066-108CreamOver the counter monograph drugsApril 3, 2026
Headhunter surf screen spf 50 sunscreen84066-107CreamOver the counter monograph drugsNovember 10, 2025
X20hair anti fungalfolliculitisshampoo84066-106LiquidOver the counter monograph drugsMay 20, 2025
Absolut Skin SPF 50 Moisturizing Sunscreen84066-105CreamOver the counter monograph drugsApril 10, 2025
Spf 50 mineral sunscreen lip84066-104CreamOver the counter monograph drugsJuly 3, 2024
Sunscreen lip protectionbroad spectrum spf 1584066-103GelOver the counter monograph drugsJuly 2, 2024
Tinted facial sunscreen84066-102CreamOver the counter monograph drugsFebruary 21, 2024
Sunscreen lip balm84066-101LipstickOver the counter monograph drugsJanuary 25, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.